Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib

• Published in: Leukemia & lymphoma Vol. 58; no. 2; pp. 498 - 500
• Main Authors: Goldschmidt, Neta, Rund, Deborah
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.02.2017
• Subjects: Aged; Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Biomarkers; Biopsy; Blood Cell Count; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell - complications; Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - therapeutic use; Pyrazoles - adverse effects; Pyrazoles - therapeutic use; Pyrimidines - adverse effects; Pyrimidines - therapeutic use; Red-Cell Aplasia, Pure - diagnosis; Red-Cell Aplasia, Pure - etiology; Treatment Outcome